newsfilter
← Latest News
GlobeNewswire·

Larimar Therapeutics Announces Pricing of Underwritten Public Offering of Common Stock

BALA CYNWYD, Pa., Feb. 14, 2024 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. ("Larimar") (NASDAQ:LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today